戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d be blocked by cotreatment with SQ22536 (an adenylate cyclase inhibitor).
2 ated by dideoxyadenosine (5 nmol; n = 4), an adenylate cyclase inhibitor.
3 nosine monophosphate (cAMP); addition of the adenylate cyclase inhibitor 2',5'-dideoxyadenosine to th
4 ry when the preparation was pre-treated with adenylate cyclase inhibitors 2',3'-dideoxyadenosine (DDA
5  8-bromo-cAMP, and was blocked by H89 or the adenylate cyclase inhibitor 9-(tetrahydro-2-furanyl)-9H-
6 s or amiloride; treatment with either of two adenylate cyclase inhibitors; and application of AMP-PNP
7 en pre-treatment was with a guanylate and an adenylate cyclase inhibitor combined, NO donors had no e
8 as with a guanylate cyclase inhibitor and an adenylate cyclase inhibitor combined; in that situation,
9                     SQ22536 (100 microM), an adenylate cyclase inhibitor, did not inhibit bFGF-induce
10 h the MAPK specific inhibitor (U0126) or the adenylate cyclase inhibitor dideoxyadenosine (ddA) aboli
11              Conversely, incubation with the adenylate cyclase inhibitor dideoxyadenosine, with the p
12                              Conversely, the adenylate cyclase inhibitor, dideoxyadenosine (10 microM
13 zed by pretreatment with protein kinase A or adenylate cyclase inhibitors, H89 and di-deoxyadenosine,
14 ase inhibitor methylene blue (M-BLU) and the adenylate cyclase inhibitor MDL combined; or (iv) the ni
15 fect of adenosine could be suppressed by the adenylate cyclase inhibitor MDL-12,330.
16  that was abolished by pretreatment with the adenylate cyclase inhibitor MDL-12.
17 lin-1-one (ODQ) or cystamine (CYS); (ii) the adenylate cyclase inhibitors nicotinic acid (NIC-A), 2',
18 ibitory only when pre-treatment was with the adenylate cyclase inhibitors nicotinic acid (NIC-A), 2',
19 -kappaB activation, and dideoxyadenosine, an adenylate cyclase inhibitor, prevented the hCG effect on
20 -chelators, Fe++-chelator, CYP450 inhibitor, adenylate cyclase inhibitor, protease inhibitors, and ni
21 urthermore, pretreatment of ganglia with the adenylate cyclase inhibitor SQ 22, 536, or the phosphodi
22 imic or occlude clonidine's actions with the adenylate cyclase inhibitor SQ 22536 nor with the non-sp
23                             In contrast, the adenylate cyclase inhibitor SQ22536 (10 micro M) and the
24 te cyclase activator forskolin (5 microM) or adenylate cyclase inhibitor SQ22536 (100 microM).
25 uppression of mitogenesis is reversed by the adenylate cyclase inhibitor SQ22536, and implicates cAMP
26 -bromo-cAMP, whereas it was abolished by the adenylate cyclase inhibitor SQ22536.
27                                           An adenylate cyclase inhibitor, SQ22536 (100 microM), did n
28 denylate cylase activator, forskolin; or the adenylate cyclase inhibitor, SQ22536.
29 oapplication with endothelin-1, bFGF, or the adenylate cyclase inhibitor, SQ22536.
30                               MDL12,330A, an adenylate cyclase inhibitor that lowers the levels of cA
31 se effects are reduced in the presence of an adenylate cyclase inhibitor, yet persist in the presence

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。